Re: Prevalence of the Metabolic Syndrome and Cardiovascular Disease Risk in Chemotherapy-Treated Testicular Germ Cell Tumour Survivors Editorial Comment

被引：0
|
作者：
Seftel, Allen
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 190卷 / 05期
关键词：
D O I：
10.1016/j.juro.2013.07.096
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1768 / 1768
页数：1
相关论文
共 50 条
  • [21] Re: Clinical Analysis of Management of Pediatric Testicular Germ Cell Tumors Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2013, 189 (04) : 1532 - 1533
  • [22] Re: Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2018, 200 (06) : 1167 - 1167
  • [23] Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors
    Boer, Hink
    Westerink, Nico-Derk L.
    Altena, Renske
    Nuver, Janine
    Dijck-Brouwer, D. A. Janneke
    van Faassen, Martijn
    Klont, Frank
    Kema, Ido P.
    Lefrandt, Joop D.
    Zwart, Nynke
    Boezen, H. Marike
    Smit, Andries J.
    Meijer, Coby
    Gietema, Jourik A.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : 104 - 111
  • [24] Re: Surgical Management of Complex Residual Masses following Systemic Chemotherapy for Metastatic Testicular Germ Cell Tumours Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2018, 200 (03) : 500 - 500
  • [25] Cardiovascular risk in testicular cancer survivors treated with chemotherapy: Incidence, significance, and practice implications
    Zoltick, BH
    Jacobs, LA
    Vaughn, DJ
    ONCOLOGY NURSING FORUM, 2005, 32 (05) : 1005 - 1009
  • [26] Re: Anti-Tumour Activity of Two Novel Compounds in Cisplatin-Resistant Testicular Germ Cell Cancer Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2013, 190 (05) : 1767 - 1768
  • [27] Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor EDITORIAL COMMENT
    Cary, Clint
    JOURNAL OF UROLOGY, 2018, 200 (01) : 134 - 135
  • [28] Editorial Comment: Effects of testicular dysgenesis syndrome components on testicular germ cell tumor prognosis and oncological outcomes
    de Melo, Andreia Cristina
    INTERNATIONAL BRAZ J UROL, 2020, 46 (05): : 741 - 742
  • [29] A risk assessment model for predicting venous thromboembolic events in chemotherapy-treated germ-cell cancer
    Luengo, M. I.
    Hervas, D.
    Sobrevilla, N.
    Garcia del Muro, X.
    Guma I Padro, J.
    Castellano, D.
    Aparicio, J.
    Sanchez Munoz, A.
    Buxo, E.
    Saenz, A.
    Aguilar, J. L.
    Valverde Morales, C.
    Fernandez Aramburu, A.
    Maroto, P.
    Espinosa, M.
    Jimenez Fonseca, P.
    Ros, S.
    Margeli, M.
    Sastre, J.
    Gonzalez-Billalabeitia, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [30] Re: Spermatogenesis in Tumor-Bearing Testes in Germ Cell Testicular Cancer Patients Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2017, 197 (06) : 1460 - 1460
12345